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Purpose: Validation of MRI-guided tumor boundary delineation for targeted prostate cancer therapy
is achieved via correlation with gold-standard histopathology of radical prostatectomy specimens.
Challenges to accurate correlation include matching the pathology sectioning plane with the in vivo
imaging slice plane and correction for the deformation that occurs between in vivo imaging and
histology. A methodology is presented for matching of the histological sectioning angle and position
to the in vivo imaging slices.
Methods: Patients (n= 4) with biochemical failure following external beam radiotherapy underwent
diagnostic MRI to confirm localized recurrence of prostate cancer, followed by salvage radical
prostatectomy. High-resolution 3-D MRI of the ex vivo specimens was acquired to determine the
pathology sectioning angle that best matched the in vivo imaging slice plane, using matching anatom-
ical features and implanted fiducials. A novel sectioning device was developed to guide sectioning
at the correct angle, and to assist the insertion of reference dye marks to aid in histopathology
reconstruction.
Results: The percentage difference in the positioning of the urethra in the ex vivo pathology sections
compared to the positioning in in vivo images was reduced from 34% to 7% through slicing at the
best match angle. Reference dye marks were generated, which were visible in ex vivo imaging, in the
tissue sections before and after processing, and in histology sections.
Conclusions: The method achieved an almost fivefold reduction in the slice-matching error and
is readily implementable in combination with standard MRI technology. The technique will be
employed to generate datasets for correlation of whole-specimen prostate histopathology with in vivo
diagnostic MRI using 3-D deformable registration, allowing assessment of the sensitivity and speci-
ficity of MRI parameters for prostate cancer. Although developed specifically for prostate, the method
is readily adaptable to other types of whole tissue specimen, such as mastectomy or liver resection.
C 2016 American Association of Physicists in Medicine. [http://dx.doi.org/10.1118/1.4941016]
Key words: pathology correlation, histopathology, prostate cancer, magnetic resonance imaging,
registration, MRI-guided targeted therapy
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1. INTRODUCTION
MRI has been demonstrated as a powerful tool for mapping
the spatial extent of prostate cancer (PCa) for targeted ther-
apy such as high dose rate brachytherapy1 and MRI-guided
biopsy,2 e.g., T2-weighted (T2w) signal,3 and parameters from
diffusion-weighted imaging (DWI)3 and dynamic contrast
enhanced MRI (DCE-MRI).4 However, the sensitivity and
specificity of imaging parameters is determined by comparison
with the gold-standard of histology. Retrospective evaluation
can be made after radical prostatectomy, by correlation with
a digital reconstruction of whole-mount histopathology.5 This
task is highly challenging, as deformation occurs from multi-
ple influences between the in vivo state and histology,6 and it
can be difficult to relate the anatomy of an ex vivo specimen to
its in vivo orientation. Precise slice matching to in vivo imaging
is critical, as the foci of early stage PCa are likely to be smaller
than the pathology section width (typically 3 mm).
This work presents a robust and readily implementable
methodology for correlation of whole-mount prostate histopa-
thology with in vivo imaging, using intermediate ex vivo MRI
to determine the pathology sectioning plane, while employing
a novel in-house developed sectioning device to guide slicing
in this plane. The sectioning device also facilitates the insertion
of dye tracks to guide reconstruction of the 3-D histopathology
volume, and reference dye marks to verify the accuracy of
the pathology slice planes. An initial clinical evaluation of the
methodology is presented.
2. METHODS
The workflow for the methodology involved a sequence
of in vivo and ex vivo imaging and correlation techniques
(Fig. 1).
2.A. Patient recruitment
Prostate cancer patients (n = 4) with biochemical failure
after radiotherapy were enrolled in an institutional Research
Ethics Board approved prospective clinical trial to map sites
of local recurrence. Subsequent to a confirmed diagnosis from
MRI and MR-guided biopsy, patients proceeded to radical
prostatectomy.
2.B. In vivo imaging
Patients were imaged on a 1.5-tesla (T) MRI scanner (GE
Signa Infinity) with a pelvic coil and an endorectal coil
(MEDRAD MRInnervu). To minimize prostate deformation,
the balloon of the endorectal coil was not inflated. The imag-
ing examination included DWI, DCE-MRI, and T2w imag-
ing. The T2w imaging was a conventional diagnostic axial
fast spin-echo (FSE) acquisition: echo time (TE) = 102 ms;
repetition time (TR) = 4650 ms; echo train length (ETL)
= 16; field of view (FOV) = 140×140 mm2; imaging matrix
= 512×512; pixel in-plane dimension = 0.273×0.273 mm2;
and slice thickness = 3 mm. Imaging was acquired axial to
the endorectal coil. The areas suspicious for cancer were
selected on the images by the oncologist (CM) using MIPAV
(NIH, Bethesda, MD), on the basis of reduced T2w signal and
evidence of extra-capsular extension.
2.C. Postsurgery anatomical marking with tissue dye
The surfaces of the prostate specimens were marked with
tissue dye as a reference of anatomical orientation: apex
= yellow; right side= red; left side= green; and black dye was
inserted through the urethra.
2.D. High-resolution MRI of ex vivo prostate at 7 T
To estimate the pathology sectioning angle and to determine
the deformation during fixation, the ex vivo prostate was MRI
scanned pre- and postfixation. To prevent MRI susceptibility
artifacts at air–tissue boundaries, the specimen was embedded
in a block (7×7×7 cm3) of gel (4% gelatin, 1.5% agarose),
resting flat on the posterior surface above 1 cm of gel, and
such that the axes of the specimen and block were aligned.
The block was imaged in a 7-T preclinical MRI scanner (70/30
BioSpec, Bruker, Ettlingen, Germany), using a quadrature
volume resonator (15.5 cm inner diameter) for transmission
and reception. High magnetic field strength facilitated access
to higher signal to noise ratios at high resolution, for enhanced
anatomical mapping. A spin-echo sequence, rapid acquisition
with relaxation enhancement (RARE) was used to obtain a
T2w 3-D isotropic high-resolution acquisition of the block.
The sequence parameters were TE = 68 ms, TR = 2400 ms,
ETL = 16, FOV = 70× 70× 70 mm3, imaging matrix = 233
×233×233, voxel dimension= 0.3×0.3×0.3 mm3 (approxi-
mately matching the in vivo in-plane voxel dimension). The
scan acquisition time was about 2 h. Postfixation, TE was
reduced to 40 ms, to compensate for fixation-mediated reduc-
tion in the transverse relaxation time, T2.9
2.E. Pathology sectioning angle estimation
from ex vivo MRI
Prostate specimens are typically positioned on the posterior
surface (closest to the rectum) prior to sectioning. Therefore, to
match sectioning to in vivo imaging, estimation must be made
of the angle in the anterior–posterior direction between the
posterior surface and the coil axis (axis of imaging), denoted
α1, and also the left–right angle between the main axes of
the prostate and coil, denoted α2. Angles α1 and α2 were
initially estimated using the prefixation ex vivo MRI data, and
updated postfixation. The oncologist (CM) contoured the pros-
tate boundaries and identified salient anatomical features on
all images using (The MathWorks, Natick, MA). Three
implanted gold seed fiducials (length 3–5 mm, diameter 1 mm)
were visible as focal hypointensities for three patients (#2–#4),
both in vivo and ex vivo. Contours were drawn around each
marker artifact, allowing centroid calculation. A 3-D rotational
transform between the in vivo and ex vivo states was calculated
from the marker centroids, which provided estimates of α1 and
α2.
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F. 1. Pathology correlation workflow. Ex vivo MRI of the specimen determines the pathology sectioning angle for best match with in vivo imaging. A
sectioning device is employed in four steps, to guide pathology sectioning and create reference marks for histopathology reconstruction.
Implanted fiducial markers were not visible for patient #1,
necessitating the use of distance metrics for angle estimation
(Fig. 2). Four distances were measured to the center of the ure-
thra in corresponding in vivo and ex vivo slices: d1: the distance
from the anterior surface; d2: from the posterior surface; d3:
from the left surface; d4: from the right surface. The ratios of








The axial (to the posterior surface) ex vivo data were digitally
resampled at varying axial oblique angles (α1) from −30◦ to
+30◦ in steps of 5◦, and down-sampled to create 3-mm thick
slices, to match the in vivo slices. The α1 was identified that
minimized the mean square difference between in vivo and
ex vivo ratios. For final refinement, α1 was varied through
increments of 1◦ in the vicinity of the minimum. Angle α2
was determined by rotation of the α1-rotated data through
increments of 1◦ from −5◦ to +5◦.
2.F. Sectioning device
A sectioning device (Fig. 3) was designed for MRI-guided
matching of the sectioning planes to in vivo imaging. It con-
sisted of an acrylic mold with detachable sides, and a series
of attachments and guidance plates made from polycarbon-
ate (ABS blend), which were generated by fast prototyping
using a Stratasys Vantage 3-D printer (Stratasys, MN). The
hypodermic needles employed were 21G and 12 cm long (B.
Braun Melsungen AG, Germany), and the tissue dye (Bradley
Products, Inc., MN) was diluted in a 1:5 ratio with ultrasound
(U/S) gel, to limit diffusion and leakage.
2.G. Sectioning device use #1: Insertion of needle
tracks through the tissue
On completion of the fresh state ex vivo MRI, α1 and α2
were estimated. The specimen was removed from gel, and
two needles were inserted in the tissue perpendicular to the
determined sectioning plane [Fig. 3(c)], which were left in
place during fixation to create holes that would be visible in
histology. For fixation, the specimen was submersed for 60
h in 10% neutral buffered formaldehyde solution (formalin).
Once removed from formalin, dye was inserted during needle
removal, to help distinguish the needle marks from other fea-
tures.
2.H. Sectioning device use #2: Setting angle
and position of the sectioning guidance plate
On completion of the fixed state ex vivo MRI, α1 and α2
were updated. The mold was preset with a 1-cm gel layer,
upon which the specimen was placed on its posterior sur-
face. (α2 was not found to differ from zero for any specimen,
however in the instance where α2 is nonzero, a protractor
may be employed to position the specimen accordingly.) For
immobilization, another 1-cm layer of gel was poured around
the specimen and allowed to set.
The pathology section thickness matched the in vivo MRI
slice thickness (3 mm). For optimum sampling of disease
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F. 2. Estimating α1 and α2 by comparison of distance metrics between in vivo and (prefixation) ex vivo MRI data sets. (a) On the in vivo image distances are
measured between the center of the urethra and the anterior (d1), posterior (d2), left (d3), and right (d4) edges, from which the ratios r1,2 and r3,4 are calculated.
(b) The metrics are measured on the ex vivo MRI slice and the ratios compared with in vivo data. (An in-plane rotation was also required to compensate for
rotation of the specimen caused by extraprostatic tissue on the posterior surface.) (c) The ex vivo data rotated by α1= 20◦ give the best match to in vivo ratios.
margins at the apex, the width of the first section at the apex
should be close to 3 mm. Hence, the objective was to position
the first plate in the 3-mm slice immediately before the first
slice containing tissue [Fig. 3(d)]. A set of 1-mm thick T2w
MR imaging slices was acquired at α1. It was deemed that
the plate position and angle was correct when the U/S-gel
filled grooves were visible in the last 1-mm slice before the
apex.
F. 3. Sectioning device. (a) Plate type A (width= 9 cm, height= 5.5 cm, thickness= 3 mm) with 1-mm deep grooves for needle-guidance, and to create
MR-visible reference tracks when filled with ultrasound gel. (b) Plate type B (same dimensions as type A) with slots for guiding needles through plate. [(c), (f)]
Device includes a rectangular mold (length= 25 cm, width= 10 cm), and guide rails for holding plates, with a pivot to set the angle. (c) Use #1: guiding needles
through type B plate and perpendicular to the slicing plane. (d) Use #2: setting the angle of the type A plate to the slicing angle. (Side view depicts the urethra
trajectory.) (e) Use #3: All type A plates are fitted at the slicing angle, and needles are guided into tissue surface to create reference dye marks for sectioning. (f)
Use #4: Type B plate is fitted to the last slot and at the same angle, and needles are positioned through the plate to create tracks through the gel that will embed
the tissue.
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2.I. Sectioning device use #3: Insertion of dye marks
at the sectioning positions
All the type-A plates were fitted and set to α1 [Fig. 3(e)].
A needle was guided along the grooves in each plate to insert
dye markers of about 1 cm in depth into the tissue, by first
depositing a small quantity on the surface, followed by slowly
inserting the needle while not applying pressure to the syringe.
Marks were made at 5-mm intervals across the slicing planes,
which were separated by 3 mm. The dye color was varied
between plates in a repeating sequence of three colors, to
distinguish neighboring planes. On completion, all plates, with
the exception of the first, were removed, and the last plate was
replaced by a type-B plate. These two plates would remain in
place to guide pathology sectioning, and furthermore the type-
B plate would be used for the work described in Sec. 2.J.
2.J. Sectioning device use #4: Insertion of needle
tracks through the gel
Four needles were pushed through the type-B plate and
positioned alongside the tissue [Fig. 3(f)]. These would create
tracks in the embedding gel, which would guide stacking of
the digital images of the tissue sections during histopathology
reconstruction. The mold with the specimen, plates, and nee-
dles in place was filled with gel and refrigerated overnight.
To increase track visibility, dye was deposited during needle
removal.
2.K. Pathology sectioning
To prepare the specimen for sectioning, first the sides of the
mold were detached from the gel block in which the specimen
was embedded, and the guide rails were also removed. The
specimen would remain embedded in gel during sectioning.
Furthermore, the two guidance plates (see Sec. 2.I) would
remain embedded in the gel with the specimen, to help guide
sectioning. A rotary blade meat slicer was used for sectioning
and the sectioning angle on the slicer was set by use of a
rectangular wedge of gel, which was prepared at the best match
angle α1. The gel block containing the specimen was placed
on top of the wedge block, and both were trimmed so that the
combined cutting edge was parallel to the embedded plates.
The block and wedge were placed on the holding tray of the
slicer so that the apex would be sliced first. The pathologist
(TvdK) performed all histological sectioning. Once slicing had
reached the first (type A) plate, the block and wedge were
removed from the slicer and the plate was detached. Some gel
protruded from where the rectangular opening in the plate had
been, and this was carefully trimmed by hand to create a tight
fit with the back plate of the slicer. The block and wedge were
repositioned on the slicer, verifying that the slice plane was par-
allel to the remaining plate. The next slice consisted of the first
slice of the apex, and slicing continued for the whole specimen.
The sections were ordered in sequence during slicing, with the
surrounding gel kept in place, and were digitally captured at
high resolution using a camera mounted at a fixed height, while
resting on a 1-mm spaced grid to indicate the dimensions.
2.L. Histopathology processing
The tissue sections were processed in a histoprocessor,
embedded in paraffin and sliced on a sledge microtome to
produce one 5-µm whole-mount histology slide section from
the top of each block, which was stained with Hematoxylin
and Eosin (H&E). The slides were digitized at 5 µm resolution
on a TISSUEscope™ 4000 (Biomedical Photometrics, Inc.,
ON, Canada) and digitally annotated by the pathologist using
  software (Aperio Technologies, Inc., CA).
3. RESULTS
3.A. Pathology slicing angle estimation
from ex vivo MRI
For specimen #1, estimates of α1 and α2 were 20◦ and
0◦, respectively, before fixation, and were unchanged after
fixation. The estimated angles for specimens #2–#4 (Table I)
(i.e., with fiducial markers) were similar to those of specimen
#1, and approximately consistent before and after fixation,
with an average α1 of 17◦ both pre- and postfixation, while
α2 was 0◦ for all specimens. Angle variation after fixation is
likely due to tissue deformation. A possible added influence
is pressure from the plate guiding the needles during use #1,
and care was taken to avoid this (subsequent to the differing
angle result of specimen #2), by ensuring that the plate was
supported underneath.
The in vivo MRI r1,2 values for an example slice near the
apex were compared with the ratios in postfixation ex vivo
MRI axial to the posterior surface, postfixation ex vivo MRI
resampled at α1, and the tissue slice photograph. The r1,2 errors
were calculated from estimated uncertainties of 1 mm for the
tissue edge and the urethra center. For specimen #1, the r1,2
ratio measured on in vivo MRI was 1.9 ± 0.4, and on the
ex vivo postfixation slice without digital resampling r1,2 was
2.6 ± 0.6 (37% difference). After digital resampling of the
ex vivo data, the r1,2 ratio was 1.9 ± 0.4, which matched the
in vivo ratio. After sectioning, r1,2 on the tissue slice photo-
graph was 1.8 ± 0.4; a difference of −5% with the in vivo
r1,2. The ratios and percentages were similar for specimens
#2–#4 (Table II). A substantial improvement in spatial match-
ing was achieved with resampling at α1, i.e., the mean absolute
percentage difference of r1,2 was reduced from 34(±18)% to
12(±4)%.
T I. Results of angle estimation from ex vivo MRI data for specimens
#2–#4.
Prefixation Postfixation
Specimen No. α1 (deg) α2 (deg) α1 (deg) α2 (deg)
2 10 0 5 0
3 20 0 20 0
4 20 0 25 0
Mean(±std) 17(±6) 0 17(±10) 0
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T II. For specimens #2–#4, r1,2 values for example matching slices near the apex for in vivo MRI, ex vivo MRI, ex vivo MRI resampled at α1, and in the







% ∆ (r1,2 ex vivo
MRI −r1,2 in vivo
MRI) (%)
r1,2 ex vivo MRI
resampled at α1






% ∆ (r1,2 tissue slice
−r1,2 in vivo MRI)
(%)
2 1.5 ± 0.2 1.7 ± 0.3 13 1.6 ± 0.3 7 1.5 ± 0.3 0
3 1.6 ± 0.3 2.3 ± 0.5 44 1.4 ± 0.3 −13 1.6 ± 0.3 0
4 2.0 ± 0.4 2.9 ± 0.7 45 2.3 ± 0.6 15 1.6 ± 0.3 −20
Mean absolute % ∆ 34(±18) 12(±4) 7(±12)
3.B. The sectioning device
3.B.1. Use #1
The dye tracks were visible in the postfixation ex vivo MRI
[Fig. 4(a)], and in the tissue sections [Fig. 4(b)]. While the
dye was found to mostly wash away during the histology
processing before paraffin embedding [Fig. 4(c)], the holes
created by the needles were still clearly visible with some
indication of the dye around the rim. Furthermore, these holes
were visible on the histology sections [Fig. 4(d)].
3.B.2. Use #2
The U/S gel in the grooves of the type-A plate was predom-
inantly visible in the last 1-mm slice before the apex. The
uncertainty on the positioning of the 1-mm wide and 15-
mm long grooves in a 1-mm wide imaging slice was esti-
mated as half the depth of the groove, at 0.5 mm (i.e., partial
volume averaging with neighboring slices). Therefore, the
uncertainty on the setting of α1 was arctan(0.5/15) = 1.9◦.
The average error on r1,2 for specimens #2–#4 for the tis-
sue slice photographs was 7(±12)%, which is lower than
the average error for the resampled ex vivo MRI [12(±4)%]
(Table II), demonstrating that the step of setting the section-
ing angle by use of the sectioning device did not inflate the
errors.
3.B.3. Use #3
The dye marks inserted at the planned sectioning positions
were visible in some sections after slicing. Owing to variable
pressure applied during sectioning on the slicer, the section
thickness was found to vary slightly (typically between 2.9
and 3.1 mm) and these errors could accumulate through slic-
ing, and hence sectioning did not always occur at the pre-
defined positions. However, when visible it was possible to
verify accuracy of the slice plane angle in the left–right direc-
tion, by comparing marker visibility on the left and right.
The dye marks were found to be robust to all processing
steps (cycles of formalin, ethanol, xylene, and paraffin in the
histoprocessor) to create the paraffin blocks [Fig. 4(g)]. This
added a further reference for the left–right angle during histol-
ogy sectioning on the microtome. Needle tracks correspond-
ing to these dye marks were visible on the histology slides
[Fig. 4(h)].
3.B.4. Use #4
The needle tracks made through the gel were visible on
photography of the sections, with some of the dye remaining
in the tracks [Fig. 4(b)].
3.C. Comparison of slices from in vivo to histology
Correlation of anatomical features was observed between in
vivo MRI, ex vivo MRI, section photography, paraffin blocks,
and histology (Fig. 4). Furthermore, there was initial indi-
cation of coincidence of disease margins between diagnostic
MRI [Fig. 4(e)] and histology [Fig. 4(h)]. Extraprostatic tissue
removed with the prostate provided extra cross-referencing
features for slice matching between ex vivo data. However, in
histology, this extra tissue (sometimes combined with residual
gel from the block) tended to fragment [Figs. 4(d) and 4(h)].
4. DISCUSSION
4.A. Comparison with other methods
In the prostate, the urethra follows an arc-shaped path
[Fig. 3(d)], and therefore slicing perpendicular to an arbitrary
axis of the urethra7,8 can give rise to an angle mismatch of
as much as 15◦.7 Langer et al.10 imaged ex vivo specimens at
multiple axial oblique angles in increments of 5◦ to match in
vivo imaging. In another study, an organ mold was designed
from in vivo images, in which the specimen was fixed, imaged,
and sliced.11 However, tissue can deform in the mold during
fixation. Image-guided magnetically tracked probes have also
been used to indicate the sectioning plane on the ex vivo
specimen.6 In contrast, the method presented here is readily
implementable with standard MRI technology.
4.B. Pathology slice angle estimation
Angle estimation from in vivo imaging was inaccurate, as
the 3-mm thick imaging slices provided very approximate
information on the prostate shape, and it was not known how
the ex vivo specimen would align on the posterior surface.
The angle estimates from ex vivo imaging were generally
similar between specimens, suggesting a common anatomical
orientation and a predictable compression by the coil. For the
distance metric approach, errors were estimated based on a
1 mm uncertainty in contour and feature selection. For the gold
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F. 4. Matching images for MRI and histology. [(a)–(d)] Slice position
toward prostate base. [(e)–(h)] Central slice position. (a) Ex vivo postfixation
MRI resampled at α1. Arrows indicate dye tracks from use #1. (b) Photograph
of tissue section with gel. Arrows inside tissue indicate dye tracks from use
#1, while arrows outside tissue indicate dye tracks from use #4. (c) Paraffin
block after removal of histology slide section. Arrows indicate holes corre-
sponding to tissue dye tracks from use #1. (d) H&E stained histology slide
with tumor areas marked by pathologist. Arrows indicate holes corresponding
to dye tracks from use #1. Some residual gel is present around the tissue. (e)
In vivo T2w MRI showing contour of prostate and tumor areas as determined
by the oncologist. (f) Ex vivo prefixation MRI of matching slice resampled at
α1. (g) Paraffin block after removal of histology section. Arrows indicate
the dye marks from use #3. (h) H&E stained histology slide with tumor
areas marked by the pathologist. Arrows indicate tracks of marks from use
#3.
seeds method, the uncertainty was dependent on the artifact
boundary selection. However, as the artifact dimensions vary
between frequency-encode and phase-encode directions, and
with magnetic field strength and readout bandwidth, the over-
all uncertainty was difficult to assess, and will be the subject
of future work. However, further studies are required with
larger numbers of specimens to fully explore the variability
of prostate anatomy between individuals and the accuracy of
pathology slice matching using this methodology.
4.C. Benefits of the sectioning device
The device provided a means of guiding pathology section-
ing at the angles and positions which were estimated to best
match the in vivo imaging planes. Even though prostate tissue
is likely to undergo deformation from multiple influences be-
tween in vivo imaging and histology [i.e., deformable registra-
tion is included in the proposed pipeline to reduce errors from
these effects (Fig. 1)], matching of the pathology slice angles to
in vivo imaging is still a critically important step in the process.
Given that the dimension of the foci of early stage PCa could be
less than the pathology tissue slice thickness (3 mm), and that
typically only a single histology slide is created from the top of
each pathology section, it is vital to match the histology slice
angles with the best estimates of the in vivo imaging angles.
The device also ensured an adequate width of the first tissue
section, which permits more precise sampling at the margins
(e.g., with multiple-step histology).
The dye tracks through the tissue and gel provided a refer-
ence for histopathology reconstruction, and the tissue tracks
could be used to assess deformation during processing. Al-
though no needle deformation was discernable during needle
insertion in the tissue or gel, slight deviations in the nee-
dle trajectory may occur. However, these deviations might be
detectable in the postfixation MRI data, and examination of
the data for these potential effects should be included in future
implementations of this process. The dye marks at the planned
sectioning positions indicated the slicing plane accuracy, and
assisted histology slicing on the microtome.
The data obtained will be used in 3-D finite element model-
ing (FEM) biomechanical-based deformable registration12–14
of the histopathology volume to the in vivo volume in a step-
wise process through the tissue states: (1) histopathology to ex
vivo fixed MRI; (2) the result of 1 to ex vivo fresh MRI; (3) the
result of step 2 to in vivo MRI.
5. CONCLUSIONS
A methodology has been presented for correlation of
whole-specimen prostate histopathology with in vivo diag-
nostic MRI. Ex vivo MRI was employed to determine the
pathology sectioning angle, and a novel sectioning device was
demonstrated as an important tool to guide sectioning, and
to allow creation of reference dye marks to aid in histopa-
thology reconstruction. The process is easily implemented
with standard MRI technology and is also readily adaptable
to other tissue types, such as mastectomy or liver resections.
The data obtained will be used to register histopathology with
in vivo imaging to determine the sensitivity and specificity of
diagnostic MRI parameters to prostate cancer.
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